Safety Study of Human Spinal Cord-derived Neural Stem Cell Transplantation for the Treatment of Chronic SCI

NCT01772810 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Spinal Cord Injury (SCI)

Interventions

DRUG: Human spinal cord stem cells.

Sponsor

Neuralstem Inc.